Retinal vein occlusion
Abstract
Retinal vein occlusion is a common disease, especially in the elderly, and is associated with significant visual morbidity, as a consequence of persistent macular oedema, macular ischemia, and in the advanced stages of the disease, due to retinal or iris neovascularisation with vitreal haemorrhages or neovascular glaucoma. There are two types of retinal vein occlusion with respect to the site of occlusion: branch retinal vein occlusion and central retinal vein occlusion. The obstruction is mainly due to external compression of the rigid artery over a vein. The main risk factors for retinal vein occlusion are established cardiovascular risk factors: hypertension, hyperlipidemia and diabetes mellitus, whereas inherited or acquired types of trombophilia play a minor role. An overview of diagnostic and treatment aproaches, and guidlines for follow-up of patients with retinal vein occlusion are presented.Downloads
Downloads
Published
Issue
Section
License
The Author transfers to the Publisher (Slovenian Medical Association) all economic copyrights following form Article 22 of the Slovene Copyright and Related Rights Act (ZASP), including the right of reproduction, the right of distribution, the rental right, the right of public performance, the right of public transmission, the right of public communication by means of phonograms and videograms, the right of public presentation, the right of broadcasting, the right of rebroadcasting, the right of secondary broadcasting, the right of communication to the public, the right of transformation, the right of audiovisual adaptation and all other rights of the author according to ZASP.
The aforementioned rights are transferred non-exclusively, for an unlimited number of editions, for the term of the statutory
The Author can make use of his work himself or transfer subjective rights to others only after 3 months from date of first publishing in the journal Zdravniški vestnik/Slovenian Medical Journal.
The Publisher (Slovenian Medical Association) has the right to transfer the rights of acquired parties without explicit consent of the Author.
The Author consents that the Article be published under the Creative Commons BY-NC 4.0 (attribution-non-commercial) or comparable licence.
